EcoDrugPlus

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSOPRG00000000068
Gene Symbol: IMPDH2
1 Cross references
200 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSOPRG00000014301
Gene Symbol: INPP5D
1 Cross references
213 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSOPRG00000008781
Gene Symbol: ITGA2B
1 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSOPRG00000008550
Gene Symbol: ITGA4
1 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSOPRG00000015699
Gene Symbol: ITGA5
3 Cross references
269 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSOPRG00000011304
Gene Symbol: ITGAV
1 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSOPRG00000003554
Gene Symbol: ITGB1
1 Cross references
299 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSOPRG00000006846
Gene Symbol: ITGB3
1 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSOPRG00000010449
Gene Symbol: ITGB5
1 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSOPRG00000012408
Gene Symbol: ITGB6
1 Cross references
206 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSOPRG00000005758
Gene Symbol: ICAM1
3 Cross references
93 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSOPRG00000008198
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).